Clinical Trial Update: Fluorescent Dyes for Lymph Node Mapping [Phase 1]

View source ↗

Summary

This document reports the completion of a Phase 1 clinical trial at MD Anderson Cancer Center evaluating fluorescent dyes for sentinel lymph node mapping in bre…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Breast Cancer | Phase 1 | Status: COMPLETED